# Natco Pharma Ltd. - Chemical Division - Inspection Records

Source: https://www.keypedia.com/companies/natco-pharma-ltd-chemical-division/3d56c2ac-4a7d-4f9f-8987-966d0ff5e5f1

> Inspection records and compliance data for Natco Pharma Ltd. - Chemical Division in Rangareddy District, None. Access full analysis and detailed observations.

---

## Details

- Name: Natco Pharma Ltd. - Chemical Division
- FEI Number: 3004065860
- City: Rangareddy District
- State: None
- Country Name: India
- Address Line 1: Mekaguda Village, Nandigama Mandal
- Zip Code: None
- Business Operations: API MANUFACTURE

## Related Documents

- [FDA Inspection 1275209 - Natco Pharma Ltd. - Chemical Division - 2025-06-13](https://www.keypedia.com/records/fda_inspections/natco-pharma-ltd-chemical-division/fe9a831b-e0da-4681-ae9a-15851f2fff24) — source: FDA, date: June 13, 2025
- [FDA Inspection 1275209 - Natco Pharma Ltd. - Chemical Division - 2025-06-13](https://www.keypedia.com/records/fda_inspections/natco-pharma-ltd-chemical-division/e5186ff1-bf05-47b7-9874-f62b160ec29c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 13, 2025
- [483 - Natco Pharma Ltd. - Chemical Division - 2019-08-09](https://www.keypedia.com/records/483/natco-pharma-ltd-chemical-division/5ea9e86e-9e64-446e-9b6b-764431d2ed8b) — source: FDA, date: August 9, 2019
- [FDA Inspection 1099291 - Natco Pharma Ltd. - Chemical Division - 2019-08-09](https://www.keypedia.com/records/fda_inspections/natco-pharma-ltd-chemical-division/f3508ce8-cdfe-42a8-acd7-8d4dd110fcb9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 9, 2019
- [FDA Inspection 1052872 - Natco Pharma Ltd. - Chemical Division - 2018-02-16](https://www.keypedia.com/records/fda_inspections/natco-pharma-ltd-chemical-division/aaf0a205-9d12-4646-8551-0e04c9cbe25b) — classification: No Action Indicated (NAI), source: FDA, date: February 16, 2018
- [FDA Inspection 903169 - Natco Pharma Ltd. - Chemical Division - 2014-10-13](https://www.keypedia.com/records/fda_inspections/natco-pharma-ltd-chemical-division/36287452-df96-4b27-92e3-e92bec559c3e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 13, 2014
- [FDA Inspection 762071 - Natco Pharma Ltd. - Chemical Division - 2011-11-24](https://www.keypedia.com/records/fda_inspections/natco-pharma-ltd-chemical-division/a3d574ca-3ec3-4e8e-a2cd-c28a099e553e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 24, 2011

## Related Companies

- [ISP Chemicals LLC](https://www.keypedia.com/companies/isp-chemicals-llc/8523c955-e979-40c7-afae-92f881ffe0d0)
- [Strem Chemicals, Inc.](https://www.keypedia.com/companies/strem-chemicals-inc/285a934f-0fb3-4204-8233-4b3fc4364d64)
- [Zhejiang Guobang Pharmaceutical Co., Ltd](https://www.keypedia.com/companies/zhejiang-guobang-pharmaceutical-co-ltd/26334d34-b5ce-4ef2-ab1d-455003edad45)
- [Wuhan Biocause Pharmaceutical Development Co., Ltd.](https://www.keypedia.com/companies/wuhan-biocause-pharmaceutical-development-co-ltd/79c352a3-22a2-471e-abbe-1802683656eb)
- [Zhejiang Cheng Yi Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/zhejiang-cheng-yi-pharmaceutical-co-ltd/dabc68a0-9969-418a-9cd6-54e9987ed8df)
- [Cadila Pharmaceuticals Limited](https://www.keypedia.com/companies/cadila-pharmaceuticals-limited/042118cf-4e9b-432b-b155-94c2b5e3e025)
- [Jiangxi Synergy Pharmaceutical, Co., Ltd.](https://www.keypedia.com/companies/jiangxi-synergy-pharmaceutical-co-ltd/9602f29a-9a10-4201-966c-b89b6a2d3ae5)
- [Somerville Acquisitions, Inc.](https://www.keypedia.com/companies/somerville-acquisitions-inc/195f0557-96af-4562-98e7-9e03150b33cb)
- [Arch Pharmalabs Ltd.](https://www.keypedia.com/companies/arch-pharmalabs-ltd/2766781c-7a1a-4718-bb0e-04fa9616a574)
- [Calyx Chemicals & Pharmaceuticals Limited](https://www.keypedia.com/companies/calyx-chemicals-pharmaceuticals-limited/e01c292e-7fb4-4afa-b74e-c1afc698d94d)

## Related Officers

- [Yvins Dezan](https://www.keypedia.com/people/yvins-dezan/e9fd12e6-c090-4eb6-bc78-8b80e8a90946)